Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Planned sale Chief Development Officer sold 15,344 shares at $9.18 ($140,846)
  2. 4 Grant or award Chief Medical Officer acquired 118,750 shares (grant or award)
  3. 4 Grant or award Chief Development Officer acquired 182,870 shares (grant or award)
  4. 4 Grant or award Chief Commercial Officer acquired 112,750 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 127,750 shares (grant or award)
  6. 4 Grant or award President & CEO acquired 475,000 shares (grant or award)
  7. 4 Grant or award GRAMMER ELIZABETH A acquired 127,750 shares (grant or award)
  8. 4 Grant or award Felsch Robert Ora acquired 70,120 shares (grant or award)
  9. 4 Grant or award Blanks Robert acquired 112,750 shares (grant or award)
  10. 4 Planned sale Chief Development Officer sold 30,000 shares at $6.64 ($199,200)
  11. 4 Planned sale Chief Financial Officer sold 225,000 shares at $6.36 ($1,430,123)
  12. 4 Planned sale Chief Development Officer sold 5,675 shares at $6.07 ($34,447)
  13. 4 Planned sale Chief Development Officer sold 7,000 shares at $5.55 ($38,850)
  14. 4 Planned sale GRAMMER ELIZABETH A sold 50,000 shares at $5.08 ($253,925)
  15. 4 Planned sale Chief Development Officer sold 20,000 shares at $5.27 ($105,476)
  16. 4 Planned sale Chief Development Officer sold 10,272 shares at $5.00 ($51,360)
  17. 4 Planned sale Chief Development Officer sold 3,000 shares at $4.50 ($13,500)
  18. 4 Open-market sale Chief Medical Officer sold 2,581 shares at $4.36 ($11,259)
  19. 4 Open-market sale Chief Development Officer sold 3,767 shares at $4.36 ($16,432)
  20. 4 Open-market sale Chief Commercial Officer sold 4,714 shares at $4.36 ($20,563)

Page 10 of 35 · 690 filings